The COVID-19 pandemic has affected virtually every aspect of the health care system, imposing significant barriers to providing the ongoing medical care needed by patients with chronic illnesses such as inflammatory bowel disease.
With so many of these patients dependent on regular infusion therapies, experts say it is crucial that infusion centers implement appropriate risk mitigation strategies to help ensure people can receive safe and uninterrupted care during the pandemic.
The National